Dr. Guillermo Orlando Padilla, MD

Dr. Padilla practices at Willis Knighton Pierremont in Shreveport, Louisiana.

Dr. Padilla's NPI, 1124229265, was assigned on May 29, 2007. Dr. Padilla holds Louisiana license 201457.

Dr. Padilla's primary practice is Willis Knighton Pierremont, at 8001 Youree Dr, Shreveport, LA 71115 in Caddo Parish. The practice phone is (318) 212-3003.

Dr. Padilla's primary practice is Willis Knighton Pierremont in Shreveport, Louisiana. Dr. Padilla is also affiliated with Willis Knighton North. The medical group on file is Shreveport Infectious Disease. Dmand AI also links Dr. Padilla to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padilla practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Padilla's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Padilla is board certified in infectious disease by the American Board of Internal Medicine. Dr. Padilla is licensed in Louisiana.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Padilla treats.

CMS data shows 2,942 Medicare services from Dr. Padilla across 5 procedure codes in 2024, for 450 Medicare patients. Medicare paid $210,531 for them.

CMS counts 450 Medicare patients who saw Dr. Padilla in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Padilla's median patient age at 64, with 50% women.

In 2024, Dr. Padilla wrote 657 Medicare Part D claims for 84 patients. 71% of them were for generic drugs. CMS names the drug for 500 of them, across 17 drugs with 11 or more claims each, at $286,641 in total drug cost. In 2023, CMS named 409 claims across 16 drugs.

Dr. Padilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 856 general payments to Dr. Padilla from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Melinta Therapeutics, Inc. paid the most, $86,661.

Dr. Padilla is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.